Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TEVA – Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries
TEVA
$15.38
Name : Teva Pharmaceutical Industries
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $18,986,149,888.00
EPSttm : -0.15
finviz dynamic chart for TEVA
Teva Pharmaceutical Industries
$15.38
0.45%
$0.07

Float Short %

4.66

Margin Of Safety %

33

Put/Call OI Ratio

0.64

EPS Next Q Diff

0.03

EPS Last/This Y

0.04

EPS This/Next Y

0.21

Price

15.38

Target Price

24.29

Analyst Recom

1.36

Performance Q

-1.54

Relative Volume

1.16

Beta

0.62

Ticker: TEVA




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-07TEVA16.860.5832.20695283
2025-07-08TEVA16.630.610.70705703
2025-07-09TEVA16.710.610.11707831
2025-07-10TEVA16.520.610.50709288
2025-07-11TEVA16.410.611.67710835
2025-07-14TEVA16.420.610.22701272
2025-07-15TEVA16.030.591.31716059
2025-07-16TEVA16.020.603.41722942
2025-07-17TEVA16.310.600.32724717
2025-07-18TEVA16.060.591.73726422
2025-07-21TEVA16.310.690.17640206
2025-07-22TEVA16.270.690.29645533
2025-07-23TEVA16.580.680.05650434
2025-07-24TEVA16.350.670.25658534
2025-07-25TEVA16.550.671.49662281
2025-07-28TEVA16.520.680.17651458
2025-07-29TEVA16.550.670.74658310
2025-07-30TEVA16.830.650.38685896
2025-07-31TEVA15.450.641.42688962
2025-08-01TEVA15.40.641.00701137
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-07TEVA16.864.11586.22.55
2025-07-08TEVA16.634.11516.62.55
2025-07-09TEVA16.714.11536.32.55
2025-07-10TEVA16.534.11525.72.55
2025-07-11TEVA16.404.11517.02.55
2025-07-14TEVA16.424.11521.32.55
2025-07-15TEVA16.044.11488.52.55
2025-07-16TEVA16.024.11513.82.55
2025-07-17TEVA16.314.11556.92.55
2025-07-18TEVA16.064.11536.22.55
2025-07-21TEVA16.314.11552.22.55
2025-07-22TEVA16.274.11536.42.55
2025-07-23TEVA16.584.11562.22.55
2025-07-24TEVA16.331.11524.82.54
2025-07-25TEVA16.541.11550.02.54
2025-07-28TEVA16.551.11547.42.54
2025-07-29TEVA16.541.11529.02.54
2025-07-30TEVA16.831.11558.12.54
2025-07-31TEVA15.452.71439.22.53
2025-08-01TEVA15.382.71181.82.53
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-07TEVA-90.455.913.49
2025-07-08TEVA-90.455.913.49
2025-07-09TEVA-90.455.913.49
2025-07-10TEVA-90.455.913.49
2025-07-11TEVA-90.455.913.48
2025-07-14TEVA-90.455.903.48
2025-07-15TEVA-90.455.903.48
2025-07-16TEVA-90.455.903.48
2025-07-17TEVA-90.455.903.48
2025-07-18TEVA-90.455.903.48
2025-07-21TEVA-90.455.823.48
2025-07-22TEVA-90.455.823.48
2025-07-23TEVA-90.455.823.48
2025-07-24TEVA-90.455.823.48
2025-07-25TEVA-90.455.824.66
2025-07-28TEVA-90.458.904.66
2025-07-29TEVA-90.458.904.66
2025-07-30TEVA-90.458.904.66
2025-07-31TEVA-90.458.904.66
2025-08-01TEVA-90.458.904.66
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.64

Avg. EPS Est. Current Quarter

0.71

Avg. EPS Est. Next Quarter

0.67

Insider Transactions

-90.45

Institutional Transactions

8.9

Beta

0.62

Average Sales Estimate Current Quarter

4438

Average Sales Estimate Next Quarter

4278

Fair Value

20.4

Quality Score

52

Growth Score

59

Sentiment Score

8

Actual DrawDown %

32.5

Max Drawdown 5-Year %

-46.4

Target Price

24.29

P/E

Forward P/E

5.59

PEG

P/S

1.06

P/B

2.58

P/Free Cash Flow

14.84

EPS

-0.14

Average EPS Est. Cur. Y​

2.53

EPS Next Y. (Est.)

2.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-0.91

Relative Volume

1.16

Return on Equity vs Sector %

-26

Return on Equity vs Industry %

-10.1

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

1181.8
Teva Pharmaceutical Industries
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 37000
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders – chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.
stock quote shares TEVA – Teva Pharmaceutical Industries Limited Stock Price stock today
news today TEVA – Teva Pharmaceutical Industries Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch TEVA – Teva Pharmaceutical Industries Limited yahoo finance google finance
stock history TEVA – Teva Pharmaceutical Industries Limited invest stock market
stock prices TEVA premarket after hours
ticker TEVA fair value insiders trading